Dried biological compositions and methods thereof
US-2024349730-A1 · Oct 24, 2024 · US
US2024268388A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2024268388-A1 |
| Application number | US-202218559468-A |
| Country | US |
| Kind code | A1 |
| Filing date | May 9, 2022 |
| Priority date | May 11, 2021 |
| Publication date | Aug 15, 2024 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention addresses the problem of providing an agricultural/horticultural fungicidal composition with excellent fungicidal activity and without any concern about chemical damage to useful plants. The present invention provides an agricultural/horticultural fungicidal composition comprising component (I) and component (II) as active ingredients, wherein the component (I) is a compound of formula (I) and the component (II) is, for example, a microbicide other than the component (I).
Opening claim text (preview).
1 . An agricultural/horticultural fungicidal composition comprising component (I) and component (II) as active ingredients, wherein the component (I) is at least one compound selected from a compound of the formula (I): and a salt thereof, wherein R 1 each independently represents a hydrogen atom, a C 1-6 alkyl group, or a C 1-6 alkoxy group; R 2 represents a C 1-6 alkyl group, a C 1-6 alkyl group having at least one G 1 , a C 2-6 chained unsaturated hydrocarbon group, a C 2-6 chained unsaturated hydrocarbon group having at least one G 1 , a C 3-6 cycloalkyl group, a C 3-6 cycloalkyl group having at least one G 2 , a C 6-10 aryl group, a C 6-10 aryl group having at least one G 2 , a 5- to 6-membered heterocyclyl group, or a 5- to 6-membered heterocyclyl group having at least one G 2 ; G 1 each independently represents a halogeno group, a hydroxyl group, a C 1-6 alkoxy group, a C 1-6 haloalkoxy group, a C 1-6 alkylthio group, a C 1-6 alkylsulfinyl group, a C 1-6 alkylsulfonyl group, a C 3-6 cycloalkyl group, a C 6-10 aryl group, a C 6-10 aryl group having at least one g 1 , a 5- to 6-membered heterocyclyl group, a 5- to 6-membered heterocyclyl group having at least one g 1 , or a cyano group; G 2 each independently represents a halogeno group, a C 1-6 alkyl group, a C 1-6 haloalkyl group, a hydroxyl group, a C 1-6 alkoxy group, a C 1-6 alkylthio group, a C 1-6 alkylsulfinyl group, a C 1-6 alkylsulfonyl group, a C 3-6 cycloalkyl group, a C 6-10 aryl group, a C 6-10 aryl group having at least one g 1 , a 5- to 6-membered heterocyclyl group, a 5- to 6-membered heterocyclyl group having at least one g 1 , a nitro group, or a cyano group; g 1 each independently represents a halogeno group, a C 1-6 alkyl group, a C 1-6 haloalkyl group, a C 1-6 alkoxy group, a C 1-6 haloalkoxy group, a nitro group, or a cyano group; T 1 represents a C 1-2 alkylene group or a C 1-6 alkylene group having at least one X 4 ; T 2 represents a C 1-2 alkylene group or a C 1-6 alkylene group having at least one X 4 ; and X 4 each independently represents a halogeno group or a C 1-6 alkyl group, and wherein the component (II) is a fungicide other than the component (I). 2 . The agricultural/horticultural fungicidal composition according to claim 1 , wherein the component (II) is at least one fungicide selected from the group consisting of the following: (A) Agents acting on nucleic acid synthesis and metabolism: A1) RNA polymerase I inhibitors benalaxyl, benalaxyl-M, furalaxyl, metalaxyl, metalaxyl-M, oxadixyl, ofurace, A2) adenosine deaminase inhibitors bupirimate, dimethirimol, ethirimol, A3) DNA/RNA biosynthesis inhibitors hymexazole, octhilinone, A4) DNA topoisomerase type II inhibitors oxolinic acid, (B) Agents acting on cytoskeleton and motor proteins: B1) to B3) β-tubulin polymerization inhibitors benomyl, carbendazim, fuberidazole, thiabendazole, thiophanate, thiophanate-methyl, diethofencarb, zoxamide, ethaboxam, chlorfenazole, debacarb, trichlamide, zarilamid, B4) mitosis (point of action unknown) inhibitors pencycuron, B5) delocalization inhibitors of spectrin-like proteins fluopicolide, fluopimomide, B6) actin/myosin/fimbrin function inhibitors phenamacril, metrafenone, pyriofenone, (C) agents acting on respiration: C1) complex I: NADH oxidoreductase inhibitors diflumetorim, tolfenpyrad, fenazaquin, C2) complex II: succinate dehydrogenase inhibitors benodanil, flutolanil, mepronil, isofetamid, fluopyram, cyclobutrifluram, fenfuram, carboxin, oxycarboxin, thifluzamide, benzovindiflupyr, bixafen, fluindapyr, fluxapyroxad, furametpyr, inpyrfluxam, isopyrazam, penflufen, penthiopyrad, sedaxane, isoflucypram, pydiflumetofen, boscalid, pyraziflumid, flubeneteram, furmecyclox, C3) complex III: cytochrome bc1 (ubiquinol oxidase) Qo site (cyt b gene) inhibitors azoxystrobin, coumoxystrobin, enoxastrobin, flufenoxystrobin, picoxystrobin, pyraoxystrobin, mandestrobin, pyraclostrobin, pyrametostrobin, triclopyricarb, kresoxim-methyl, trifloxystrobin, dimoxystrobin, fenaminstrobin, metominostrobin, orysastrobin, famoxadone, fluoxastrobin, fenamidone, pyribencarb, methyltetraprole, C4) complex III: cytochrome bc1 (ubiquinone reductase) Qi site inhibitors cyazofamid, amisulbrom, fenpicoxamid, florylpicoxamid, metarylpicoxamid, C5) deconjugation inhibitors of oxidative phosphorylation binapacryl, dinocap, meptyldinocap, fluazinam, C6) inhibitors of oxidative phosphorylation and ATP synthase fentin acetate, fentin chloride, fentin hydroxide, C7) ATP transport inhibitors silthiofam, C8) complex III: cytochrome bc1 (ubiquinone reductase) Qo site, stigmatellin-binding subsite inhibitors ametoctradin, (D) agents acting on amino acid and protein synthesis: D1) methionine biosynthesis (cgs gene) inhibitors cyprodinil, mepanipyrim, pyrimethanil, D2) protein synthesis (ribosomal translation termination step) inhibitors blasticidin S D3), D4) protein synthesis (ribosomal translation initiation step) inhibitors kasugamycin, kasugamycin hydrochloride, streptomycin, D5) protein synthesis (ribosomal polypeptide elongation step) inhibitors oxytetracycline (E) agents acting on signal transduction: E1) signal transduction (mechanism of action unknown) inhibitors quinoxyfen, proquinazid, E2) MAP/histidine kinase (os-2, HOG1) inhibitors in osmotic signal transduction fenpiclonil, fludioxonil, E3) MAP/histidine kinase (os-1, Daf1) inhibitors in osmotic signal transduction clozolinate, dimethachlone, iprodione, procymidone, vinclozolin, (F) agents acting on lipid biosynthesis or transport/cell membrane structure or function: F1) dicarboxyimide-based fungicides F2) phospholipid biosynthesis, methyltransferase inhibitors edifenphos, iprobenfos, pyrazophos, isoprothiolane, F3) cell peroxidation inhibitors biphenyl, chloroneb, dicloran, quintozene, tecnazene, tolclofos-methyl, etridiazole, F4) cell membrane permeability, fatty acid inhibitors iodocarb, propamocarb, propamocarb hydrochloride, prothiocarb, F5) carboxylic acid amide (CAA)-based fungicides F8) ergosterol binding inhibitors natamycin, F9) lipid homeostasis and transport/storage inhibitors oxathiapiprolin, fluoxapiprolin, (G) inhibitors of sterol biosynthesis in cell membrane G1) demethylase (erg11/cyp51) inhibitors at C14 position of sterol biosynthesis triforine, pyrifenox, pyrisoxazole, fenarimol, nuarimol, imazalil, oxpoconazole, pefurazoate, prochloraz, triflumizole, azaconazole, bitertanol, bromuconazole, cyproconazole, difenoconazole, diniconazole, epoxiconazole, etaconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imibenconazole, ipconazole, mefentrifluconazole, metconazole, myclobutanil, penconazole, propiconazole, simeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole, prothioconazole, fluoxytioconazole, furconazole, furconazole-cis, diniconazole-M, G2) Δ14-reductase and Δ8→Δ7-isomerase (erg24, erg2) inhibitors in sterol biosynthesis aldimorph, dodemorph, dodemorph acetate, fenpropimorph, tridemorph, fenpropidin, piperalin, spiroxamine, buthiobate, G3) 3-keto reductase (erg27) inhibitors in C4-position demethylation of sterol biosynthetic system fenhexamid, fenpyrazamine, G4) squalene epoxidase (erg1) inhibitors of sterol biosynthesis system pyributicarb, naftifine, terbinafine, (H) cell wall biosynthesis inhibitors: H4) chitin synthase inhibitors polyoxin, polyoxorim, H5) cellulose synthase inhibitors dimethomorph, flumorph, pyrimorph, benthiavalicarb, iprovalicarb, valifenalate, mandipropamid, (I) cell wall melanin synthesis inhibitors: I1) reductase inhibitors in melanin biosynthesis fthalide, pyroquilon, tricyclazole,
Copper · CPC title
Guanidine; Derivatives thereof · CPC title
containing >N—CO—N< or >N—CS—N< groups directly attached to a cycloaliphatic ring · CPC title
N-Aryl derivatives thereof · CPC title
having rings with four or more nitrogen atoms as the only ring hetero atoms · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.